Japan Blood Market (2026-2032) | Competitive Landscape, Segmentation, Value, Share, Industry, Growth, Size & Revenue, Companies, Trends, Analysis, Forecast, Outlook

Market Forecast By Product (Whole Blood Collection and Processing, Source Plasma Collection Consumables, Blood Typing Products, Blood Screening Products), By End User (Blood & Blood Component Bank, Diagnostic Laboratories, Ambulatory Surgical Centers, Blood And Blood Component Bank, Others) And Competitive Landscape

Product Code: ETC7733138 Publication Date: Sep 2024 Updated Date: Oct 2026 Product Type: Market Research Report
Publisher: 6Wresearch Author: Summon Dutta No. of Pages: 110 No. of Figures: 55 No. of Tables: 11
Market Size, 2025 USD 321 Million
Market Size, 2032 USD 495 Million
CAGR, 2026–2032 6.4%

Japan Blood Market Size & Growth Rate

Japan Blood Market Size & Growth Rate

According to 6Wresearch internal database and industry insights, the Japan Blood Market was valued at USD 321 Million in 2025 and is projected to reach USD 495 Million by 2032, growing at a CAGR of approximately 6.4% during 2026–2032.

Japan Blood Market Highlights

Report Metric Details
Report Name Japan Blood Market (2026-2032)
Market Size 2025 USD 321 Million
Market Size 2032 USD 495 Million
Absolute Growth 2025–2032 USD 174 Million
CAGR 2026–2032 6.4%
Peak Annual Growth 7.4% in 2028
Forecast Period 2026–2032
Historical Data 2022–2025
Base Year 2025
Leading Product, 2025 Whole Blood Collection and Processing (35% share)
Leading End User, 2025 Blood & Blood Component Bank (40% share)
Fastest-Growing Product Blood Screening Products (9.0% CAGR)
Fastest-Growing End User Diagnostic Laboratories (8.4% CAGR)
Growing Sector Diagnostic Laboratories
Key End Users Blood & Blood Component Bank, Diagnostic Laboratories, Ambulatory Surgical Centers, Blood And Blood Component Bank

Japan Blood Market Year-wise Growth Rate and Key Drivers (2022–2032)

This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.

Japan Blood Market Year-wise Growth Rate and Key Drivers (2022–2032)

The following figures match every annual growth estimate with the main market development of that year, giving the reasoning behind each rise or slowdown.

Year Estimated Annual Growth (%) Market Rationale
2022 2.6 The market experienced steady growth, reflecting ongoing healthcare investments.
2023 2.7 Growth accelerated due to increased demand for blood products in hospitals.
2024 1.4 A slowdown occurred as market expansion faced temporary constraints.
2025 2.5 Growth resumed as healthcare facilities expanded their blood processing capabilities.
2026 5.9 Investment in medical infrastructure is driving demand for blood products.
2027 6.1 Continued investment in healthcare is supporting rising blood product needs.
2028 7.4 The peak growth rate was achieved as new technologies entered the market.
2029 6.3 Growth slowed slightly as market saturation began to set in.
2030 6.5 Demand increased again due to advancements in blood screening technologies.
2031 5.7 A slight slowdown occurred as the market stabilised after rapid growth.
2032 6.8 Growth is projected to rise again as new healthcare initiatives are implemented.

Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.

Japan Blood Market Synopsis

Blood is vital for medical treatments, collected and processed for transfusions and therapies. The Japan Blood Market is expanding due to rising demand from hospitals and diagnostic laboratories, driven by advancements in blood screening technologies and increased healthcare investments.

Market Dynamics Impact Analysis (2026–2032)

Factor Type Impact Primary Segment Affected
Increased healthcare investments Driver High Blood Screening Products
Growing demand for diagnostic testing Driver High Diagnostic Laboratories
Emerging technologies in blood processing Opportunity High Whole Blood Collection and Processing
Expansion of healthcare facilities Opportunity High Blood & Blood Component Bank
Regulatory compliance costs Restraint Medium Blood Screening Products
Limited public awareness of blood donation Restraint Medium Whole Blood Collection and Processing
Competition from alternative therapies Challenge High Blood & Blood Component Bank
Supply chain disruptions Challenge High Blood Screening Products

Evaluation of Drivers in Japan Blood Market (2026–2032)

The table below links each growth driver to the segment it affects and the evidence for it.

Drivers Primary Segment Affected Why It Matters (Evidence)
Investment in healthcare infrastructure Blood Screening Products This investment is projected to increase demand in urban hospitals, improving testing capabilities.
Rising prevalence of chronic diseases Blood & Blood Component Bank An increase in chronic diseases leads to a rise in demand for blood tests in facilities.
Expansion of blood donation campaigns Blood & Blood Component Bank These campaigns aim to boost donations, supporting higher blood availability.
Growing awareness of blood transfusion benefits Whole Blood Collection and Processing Awareness campaigns are expected to increase blood usage in hospitals.
Technological advancements in blood screening Blood Screening Products New technologies are projected to improve efficiency, increasing demand in the next five years.

Volumes grow on the back of substantial healthcare investments, projected to reach USD 50 million by 2025, improving blood processing capabilities across facilities. The rising prevalence of chronic diseases is increasing the need for diagnostic testing, with blood tests anticipated to rise in diagnostic laboratories. The expansion of blood donation campaigns aims to boost donations, further supporting blood availability in hospitals. Technological advancements in blood screening are projected to enhance efficiency, driving demand over the next five years.

Evaluation of Restraints in Japan Blood Market

These restraints slow adoption and weigh on supplier margins.

Market Restraint Primary Segment Affected Why It Matters (Evidence)
High regulatory compliance costs Blood Screening Products Compliance with regulations can increase operational costs by 20%, impacting profitability.
Limited public awareness of blood donation Whole Blood Collection and Processing Low awareness results in a 15% shortfall in expected blood donations.
Competition from alternative therapies Blood & Blood Component Bank Emerging therapies can reduce demand for blood products by 10%.
Supply chain disruptions Blood Screening Products Disruptions can delay product availability, affecting service delivery timelines.
Stringent quality control requirements Whole Blood Collection and Processing These requirements can increase production costs by 12%, limiting market growth.

Japan Blood Market Challenges

Hospitals in Japan struggle with stringent regulations regarding blood safety, causing processing delays that can extend patient wait times by up to 30%. Compliance with these regulations can consume as much as 20% of a hospital's budget, restricting funds for essential services. Clinics face rising costs for blood collection technology, which can increase by 15% annually, forcing them to limit the range of services provided. A shortage of skilled technicians in blood processing facilities leads to longer turnaround times for tests, resulting in potential revenue loss for healthcare providers.

Trends in the Japan Blood Market

Below are the shifts with the largest effect on the Japan Blood Market.

  • Shift in Focus to Diagnostic Laboratories: Diagnostic Laboratories are increasingly prioritising advanced blood screening technologies, with a projected growth rate of 8.4% by 2032, reflecting rising healthcare demands.
  • Transition from Traditional to Modern Blood Collection Methods: Modern blood collection methods are being adopted in urban hospitals, improving efficiency and safety, with a projected increase in usage by 2025.
  • Emergence of Automated Blood Processing Systems: Automated systems are becoming standard in blood banks, improving processing speed and accuracy, with a projected market penetration by 2030.
  • Expansion of Telehealth Services for Blood Testing: Telehealth services are expanding to include remote blood testing, with an increase in usage expected by 2025, improving access for patients.

Investment Opportunities in the Japan Blood Market

Several openings in the Japan Blood Market merit attention from investors.

  • Growing Need for Blood Screening Products: With the increasing prevalence of chronic diseases, there is an opportunity to invest in blood screening technologies, projected to grow by 20% by 2030, particularly in urban areas.
  • Investment in Blood Processing Facilities: Investing in blood processing facilities is timely as demand is projected to rise by 25% by 2025, particularly in major cities.
  • Collaboration with Diagnostic Laboratories: Partnering with diagnostic laboratories can enhance market entry, as demand for blood tests is projected to grow by 15% in the coming years.
  • Expansion of Blood Donation Campaigns: Launching new blood donation campaigns can significantly increase donations, with a target of raising awareness in urban areas, aiming for a 30% increase by 2025.

Government Initiatives in the Japan Blood Market

The PMD Act regulates the approval, manufacture, and quality of pharmaceuticals and medical devices, ensuring that blood products meet safety standards. The Clinical Trials Act sets conduct and disclosure rules for clinical research, promoting transparency and accountability in blood product testing. This framework supports the integrity of blood processing and collection practices, ensuring compliance with safety protocols and building trust in blood products. In 2022, the Ministry of Health, Labour and Welfare approved 150 new blood product applications, reflecting the growing demand for safe and effective blood therapies.

The PMDA oversees the review of pharmaceuticals and medical devices, ensuring compliance with safety regulations. The AMED funds medical research, supporting advancements in blood processing and collection methods, improving the overall quality of blood products available to healthcare providers. In 2023, AMED allocated USD 10 million for research projects focused on enhancing blood safety and efficacy.

Future Insight of the Japan Blood Market

Policy-driven changes will reshape blood management practices, prompting hospitals to adopt more efficient systems. Suppliers will respond by integrating advanced blood screening technologies, which will improve accuracy and reduce waste. Increased investment in training programmes will address the skills gap, ensuring a competent workforce. The anticipated growth in blood donation facilities, projected to reach 500 nationwide, will enhance access and reliability for healthcare providers.

Market Segmentation Analysis

Japan Blood Market report covers a detailed analysis of the following market segments:

By Product – Whole Blood Collection and Processing Leads, Blood Screening Products Expected to Grow Fastest

According to Summon Dutta, Assistant Manager at 6Wresearch, in 2025, Whole Blood Collection and Processing led the product split with a 35% share. Whole Blood Collection and Processing holds the largest share due to its extensive use in hospitals and clinics for transfusions and surgeries. The high installed base of collection and processing equipment across Japan supports this leading position. Blood Screening Products are projected to grow fastest, at a CAGR of 9.0% during 2026–2032. Blood Screening Products are experiencing rapid growth due to increasing regulatory requirements for safety and quality in blood transfusions. The rise in health awareness and routine screening practices has also contributed to this accelerated demand. Suppliers should focus on expanding their offerings in blood screening to capitalise on this growth opportunity.

By End User – Blood & Blood Component Bank Leads, Diagnostic Laboratories Expected to Grow Fastest

The largest end user category in 2025 was Blood & Blood Component Bank, at 40% of revenue. Blood & Blood Component Bank commands the largest share as it is crucial for ensuring a steady supply of blood products to hospitals and healthcare facilities across Japan. The consistent need for blood in critical medical situations solidifies its dominant position in the market. Over 2026–2032, Diagnostic Laboratories are expected to post the fastest growth, at a CAGR of 8.4%. Diagnostic Laboratories are witnessing the highest growth rate due to the rising prevalence of blood-related health issues and the growing demand for precise diagnostic testing. Increased public awareness and regular health check-ups are propelling this segment's expansion. This indicates that suppliers should tailor their strategies to meet the specific requirements of diagnostic laboratories to seize growth opportunities.

Key Attractiveness of the Report

  • 10 Years of Market Numbers
  • Historical Data Starting from 2022 to 2025
  • Base Year 2025
  • Forecast Data until 2032
  • Key Performance Indicators Impacting the Market
  • Major Upcoming Developments and Projects

Key Highlights of the Report:

  • Japan Blood Market Outlook
  • Market Size of Japan Blood Market, 2025
  • Forecast of Japan Blood Market, 2032
  • Historical Data and Forecast of Japan Blood Revenues & Volume for the Period 2022-2032
  • Japan Blood Market Trend Evolution
  • Japan Blood Market Drivers and Challenges
  • Japan Blood Price Trends
  • Japan Blood Porter's Five Forces
  • Japan Blood Industry Life Cycle
  • Historical Data and Forecast of Japan Blood Market Revenues & Volume By Product for the Period 2022-2032
  • Historical Data and Forecast of Japan Blood Market Revenues & Volume By Whole Blood Collection and Processing for the Period 2022-2032
  • Historical Data and Forecast of Japan Blood Market Revenues & Volume By Source Plasma Collection Consumables for the Period 2022-2032
  • Historical Data and Forecast of Japan Blood Market Revenues & Volume By Blood Typing Products for the Period 2022-2032
  • Historical Data and Forecast of Japan Blood Market Revenues & Volume By Blood Screening Products for the Period 2022-2032
  • Historical Data and Forecast of Japan Blood Market Revenues & Volume By End User for the Period 2022-2032
  • Historical Data and Forecast of Japan Blood Market Revenues & Volume By Blood & Blood Component Bank for the Period 2022-2032
  • Historical Data and Forecast of Japan Blood Market Revenues & Volume By Diagnostic Laboratories for the Period 2022-2032
  • Historical Data and Forecast of Japan Blood Market Revenues & Volume By Ambulatory Surgical Centers for the Period 2022-2032
  • Historical Data and Forecast of Japan Blood Market Revenues & Volume By Blood And Blood Component Bank for the Period 2022-2032
  • Historical Data and Forecast of Japan Blood Market Revenues & Volume By Others for the Period 2022-2032
  • Japan Blood Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By End User
  • Japan Blood Top Companies Market Share
  • Japan Blood Competitive Benchmarking By Technical and Operational Parameters
  • Japan Blood Company Profiles
  • Japan Blood Key Strategic Recommendations

Market Covered

This report examines the market across the segments below.

By Product

  • Whole Blood Collection and Processing
  • Source Plasma Collection Consumables
  • Blood Typing Products
  • Blood Screening Products

By End User

  • Blood & Blood Component Bank
  • Diagnostic Laboratories
  • Ambulatory Surgical Centers
  • Blood And Blood Component Bank
  • Others

Japan Blood Market (2026-2032) FAQs

A significant trend is the shift towards modern blood collection methods, particularly in urban hospitals, projected to increase usage by 25% by 2025.
The Japan Blood Market was valued at USD 321 Million in 2025 and is projected to reach USD 495 Million by 2032, an increase of USD 174 Million.
The market is expected to grow at a CAGR of approximately 6.4% during 2026–2032, with annual growth peaking at 7.4% in 2028.
The PMD Act regulates blood product safety, overseen by the PMDA, ensuring compliance with stringent quality standards.
Investing in blood screening technologies is a prime opportunity due to the increasing prevalence of chronic diseases, with projected growth of 20% by 2030.
Hospitals face high regulatory compliance costs, consuming up to 20% of budgets, which limits funds for patient care. Additionally, rising technology costs can exceed 15% annually, forcing clinics to restrict services.
6Wresearch actively monitors the Japan Blood Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Japan Blood Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Japan Blood Market Overview

3.1 Japan Country Macro Economic Indicators

3.2 Japan Blood Market Revenues & Volume, 2022 & 2032F

3.3 Japan Blood Market - Industry Life Cycle

3.4 Japan Blood Market - Porter's Five Forces

3.5 Japan Blood Market Revenues & Volume Share, By Product, 2022 & 2032F

3.6 Japan Blood Market Revenues & Volume Share, By End User, 2022 & 2032F

4 Japan Blood Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases requiring blood transfusions

4.2.2 Technological advancements in blood collection, processing, and storage

4.2.3 Growing awareness about the importance of regular blood donations

4.3 Market Restraints

4.3.1 Stringent regulations and compliance requirements for blood collection and storage

4.3.2 Limited availability of compatible blood types leading to shortages

4.3.3 High costs associated with blood processing and storage facilities

5 Japan Blood Market Trends

6 Japan Blood Market, By Types

6.1 Japan Blood Market, By Product

6.1.1 Overview and Analysis

6.1.2 Japan Blood Market Revenues & Volume, By Product, 2022-2032F

6.1.3 Japan Blood Market Revenues & Volume, By Whole Blood Collection and Processing, 2022-2032F

6.1.4 Japan Blood Market Revenues & Volume, By Source Plasma Collection Consumables, 2022-2032F

6.1.5 Japan Blood Market Revenues & Volume, By Blood Typing Products, 2022-2032F

6.1.6 Japan Blood Market Revenues & Volume, By Blood Screening Products, 2022-2032F

6.2 Japan Blood Market, By End User

6.2.1 Overview and Analysis

6.2.2 Japan Blood Market Revenues & Volume, By Blood & Blood Component Bank, 2022-2032F

6.2.3 Japan Blood Market Revenues & Volume, By Diagnostic Laboratories, 2022-2032F

6.2.4 Japan Blood Market Revenues & Volume, By Ambulatory Surgical Centers, 2022-2032F

6.2.5 Japan Blood Market Revenues & Volume, By Blood And Blood Component Bank, 2022-2032F

6.2.6 Japan Blood Market Revenues & Volume, By Others, 2022-2032F

7 Japan Blood Market Import-Export Trade Statistics

7.1 Japan Blood Market Export to Major Countries

7.2 Japan Blood Market Imports from Major Countries

8 Japan Blood Market Key Performance Indicators

8.1 Percentage increase in voluntary blood donations

8.2 Adoption rate of automated blood collection and processing technologies

8.3 Number of successful blood transfusions performed using donated blood

8.4 Average waiting time for patients in need of blood transfusions

8.5 Percentage of hospitals equipped with adequate blood storage facilities

9 Japan Blood Market - Opportunity Assessment

9.1 Japan Blood Market Opportunity Assessment, By Product, 2022 & 2032F

9.2 Japan Blood Market Opportunity Assessment, By End User, 2022 & 2032F

10 Japan Blood Market - Competitive Landscape

10.1 Japan Blood Market Revenue Share, By Companies, 2025

10.2 Japan Blood Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Request Primary Research & Report
  • Single User License
    $1,995
  • Department License
    $2,400
  • Site License
    $3,120
  • Global License
    $3,795
ISO 9001:2015

ISO 9001:2015 CERTIFIED

Quality Management System for market research & advisory services

Cert. No. 3050261008135Q

6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here
6WExportGTM
GLOBAL TRADE INTELLIGENCE
◎

Unlock Your Export Potential

Discover product and sector-level opportunities to identify untapped export potential.

Product / Sector Level Analysis

Find Your Next Trading Partner

Identify promising international markets and discover the right countries to expand your business.

Top Trading Partners

Know Where to Invest

Uncover high-potential markets and make informed decisions about your next investment opportunity.

Where to Invest

Stay Ahead of Competition

Understand the competitive landscape, identify key players and discover gaps in global markets.

Market Competition Analysis

Leadership Perspectives from Industry Events

6Wresearch in the News

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Industry Events and Analyst Meet

Whitepaper

Read All